Investigational Site Number 376003

Jerusalem 91120

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Diffuse Large B-cell Lymphoma, Venous Thromboembolism

Studies at this site

• SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients — Completed
• Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy — Completed